Hodgkin lymphoma and Epstein-Barr virus (EBV): No evidence to support hit-and-run mechanism in cases classified as non-EBV-associated

International Journal of Cancer

Volumn 104, Issue 5, 2003, Pages 624-630

  Gallagher, Alice ^a   Perry, Jacqueline ^a   Freeland, June ^a   Alexander, Freda E ^b   Carman, William F ^c   Shield, Lesley ^a   Cartwright, Ray ^d   Jarrett, Ruth F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Hit and run; Hodgkin disease; Human herpesvirus 4; Quantitative PCR; Serology

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; GENOME; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; TUMOR CELL;

ADOLESCENT; ADULT; AGED; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; VIRAL MATRIX PROTEINS;

EID: 0037400904     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10979     Document Type: Article

References (31)

1. Jarrett RF, Armstrong AA, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996;7:S5-S10.
2. IARC. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. IARC Monogr Eval Carcinog Risks Hum 1997;70:1-492.
3. Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol 2002;13 (S1):23-9.
4. Macmahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966;26:1189-201.
5. Gutenhohn N, Cole P. Epidemiology of Hodgkin's disease. Semin Oncol 1980;7:92-102.
6. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease N Engl J Med 1981;304:135-40.
7. Glaser SL, Jarrett RF. The epidemiology of Hodgkin's disease. In: Diehl V, ed. Hodgkin's disease. London: Bailliere Tindall, 1996. 401-16.
8. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley MI, Khan G, O'Grady J, Hummel M, Preciado MV, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70:375-82.
9. Flavell K, Constandinou C, Lowe D, Scott K, Newey C, Evans D, Dutton A, Simmons S, Smith R, Crocker J, Young LS, Murray P. Effect of material deprivation on Epstein-Barr virus infection in Hodgkin's disease in the West Midlands. Br J Cancer 1999;80:604-8.
10. Grufferman S, Gilchrist GS, Pollock BH, Taylor GM, Schwartz CL, Ambinder RF. Socioeconomic status, the Epstein-Barr virus and risk of Hodgkin's disease in children [abstract]. Leuk Lymphoma 2001;42 (S2):40.
11. Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998;12:1272-6.
12. Ambinder RF. Gammaherpesviruses and "Hit-and-Run" oncogenesis. Am J Pathol 2000;156:1-3.
13. Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 1996;173:529-35.
14. Staratschek-Jox A, Kotkowski S, Belge G, Rudiger T, Bullerdiek J, Diehl V, Wolf J. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells: no evidence for the persistence of integrated viral fragments in Latent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease. Am J Pathol 2000;156:209-16.
15. Gan YJ, Razzouk BI, Su T, Sixbey JW. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Am J Pathol 2002;160:781-6.
16. Takada K, Ji Z, Fujiwara S, Shimizu N, Tanabe-Tochikura A. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene. J Virol 1992;66:5590-3.
17. Armstrong AA, Weiss LM, Gallagher A, Jones DB, Krajewski AS, Angus B, Brown G, Jack AS, Wilkins BS, Onions DE, Jarrett RF. Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia 1992;6:869-74.
18. Alexander FE, Jarrett RF, Lawrence D, Armstrong AA, Freeland J, Gokhale DA, Kane E, Taylor GM, Wright DH, Cartwright RA. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br J Cancer 2000;82:1117-21.
19. Alexander FE, Jarrett RF, Cartwright RA, Armstrong AA, Gokhale DA, Kane E, Gray D, Lawrence DJ, Taylor GM. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve). Cancer Epidemiol Biomark Prev 2001;10:705-9.
20. Henle W, Henle G. Epstein-Barr virus-related serology in Hodgkin's disease. Natl Cancer Inst Monogr 1973;36:79-84.
21. Long C, Derge JG, Hampar B. Procedure for activating Epstein-Barr virus early antigen in nonproducer cells by 5-iododeoxyuridine. J Natl Cancer Inst 1974;52:1355-7.
22. Trainor CD, Wong Staal F, Reitz MS. Comparative restriction endonuclease maps of proviral DNA of the primate type C simian sarcoma-associated virus and gibbon ape leukemia virus group. J Virol 1982;41:298-308.
23. Gallagher A, Armstrong AA, Mackenzie J, Shield L, Khan G, Lake A, Proctor S, Taylor P, Clements GB, Jarrett RF. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 1999;84:442-8.
24. Khan G, Lake A, Freeland J, Andrew L, Alexander Fe, Jackson R, Taylor P, McCruden EAB, Jarrett RF. Phenotype and frequency of EBV-infected cells in pre-treatment blood samples from patients with Hodgkin's disease. J Gen Virol, in press.
25. Chapman AL, Rickinson AB, Thomas WA, Jarrett RF, Crocker J, Lee SP. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res 2001;61:6219-26.
26. Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams & Wilkins, 2001. 2511-73.
27. Swaminathan S, Tomkinson B, Kieff E. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA 1991;88:1546-50.
28. Komano J, Maruo S, Kurozumi K, Oda T, Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 1999;73:9827-31.
29. Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N, Yamamoto N. Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett 2000;484:153-8.
30. Sugawara Y, Mizugaki Y, Uchida T, Torii T, Imai S, Makuuchi M, Takada K. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 1999;256:196-202.
31. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999;91:1376-81.